^
Association details:
Biomarker:FOXO3 underexpression
Cancer:Oral Cancer
Drug:cisplatin (DNA synthesis inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a

Published date:
12/30/2019
Excerpt:
The expression of miR-155 was significantly higher, while the expression of Foxo3a mRNA and protein was obviously lower in KB/DDP cells than that in KB cells....Increased expression of miR-155 and decreased expression of Foxo3a were associated with DDP resistance in oral cancer cells.
DOI:
10.3233/CBM-190555